BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

458 related articles for article (PubMed ID: 33252286)

  • 1. Use of Oral Anticoagulation in a Real-World Population With Device Detected Atrial Fibrillation.
    Kaplan RM; Ziegler PD; Koehler J; Landman S; Sarkar S; Passman RS
    J Am Heart Assoc; 2020 Dec; 9(24):e018378. PubMed ID: 33252286
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Practice Variation in Anticoagulation Prescription and Outcomes After Device-Detected Atrial Fibrillation.
    Perino AC; Fan J; Askari M; Heidenreich PA; Keung E; Raitt MH; Piccini JP; Ziegler PD; Turakhia MP
    Circulation; 2019 May; 139(22):2502-2512. PubMed ID: 30880434
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stroke Risk as a Function of Atrial Fibrillation Duration and CHA
    Kaplan RM; Koehler J; Ziegler PD; Sarkar S; Zweibel S; Passman RS
    Circulation; 2019 Nov; 140(20):1639-1646. PubMed ID: 31564126
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contemporary Trends in Oral Anticoagulant Prescription in Atrial Fibrillation Patients at Low to Moderate Risk of Stroke After Guideline-Recommended Change in Use of the CHADS
    Katz DF; Maddox TM; Turakhia M; Gehi A; O'Brien EC; Lubitz SA; Turchin A; Doros G; Lei L; Varosy P; Marzec L; Hsu JC
    Circ Cardiovasc Qual Outcomes; 2017 May; 10(5):. PubMed ID: 28506981
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of CHADS2 and CHA2DS2-VASC anticoagulation recommendations: evaluation in a cohort of atrial fibrillation ablation patients.
    Winkle RA; Mead RH; Engel G; Kong MH; Patrawala RA
    Europace; 2014 Feb; 16(2):195-201. PubMed ID: 24036378
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Practice Gap in Atrial Fibrillation Oral Anticoagulation Prescribing at Emergency Department Home Discharge.
    Kea B; Waites BT; Lin A; Raitt M; Vinson DR; Ari N; Welle L; Sill A; Button D; Sun BC
    West J Emerg Med; 2020 Jun; 21(4):924-934. PubMed ID: 32726266
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between device-detected burden and duration of atrial fibrillation and risk of ischemic stroke.
    Al-Gibbawi M; Ayinde HO; Bhatia NK; El-Chami MF; Westerman SB; Leon AR; Shah AD; Patel AM; De Lurgio DB; Tompkins CM; Lloyd MS; Merchant FM; Kiani S
    Heart Rhythm; 2021 Mar; 18(3):338-346. PubMed ID: 33250442
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Electronic Alert System for Improving Stroke Prevention Among Hospitalized Oral-Anticoagulation-Naïve Patients With Atrial Fibrillation: A Randomized Trial.
    Silbernagel G; Spirk D; Hager A; Baumgartner I; Kucher N
    J Am Heart Assoc; 2016 Jul; 5(7):. PubMed ID: 27451467
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral Anticoagulation and the Risk of Stroke or Death in Patients With Atrial Fibrillation and One Additional Stroke Risk Factor: The Loire Valley Atrial Fibrillation Project.
    Fauchier L; Lecoq C; Clementy N; Bernard A; Angoulvant D; Ivanes F; Babuty D; Lip GY
    Chest; 2016 Apr; 149(4):960-8. PubMed ID: 26425935
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of risk score (CHADS2 versus CHA2DS2-VASc) on long-term outcomes after atrial fibrillation ablation.
    Jacobs V; May HT; Bair TL; Crandall BG; Cutler M; Day JD; Weiss JP; Osborn JS; Muhlestein JB; Anderson JL; Mallender C; Bunch TJ
    Heart Rhythm; 2015 Apr; 12(4):681-6. PubMed ID: 25546809
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of cardiovascular implantable electronic devices in delivering individualized disease-guided management of patients with non-valvular atrial fibrillation and high bleeding risk.
    Mascarenhas DAN; Sharma M; Ziegler PD; Kantharia BK
    Acta Cardiol; 2019 Apr; 74(2):131-139. PubMed ID: 29863432
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ischemic stroke risk estimation in patients without oral anticoagulation: an observational cohort study based on secondary data from Germany.
    Wicke FS; Schaller MA; Karymova K; Beyer M; Müller BS
    BMC Cardiovasc Disord; 2019 Apr; 19(1):94. PubMed ID: 31014253
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CHA
    Harb SC; Wang TKM; Nemer D; Wu Y; Cho L; Menon V; Wazni O; Cremer PC; Jaber W
    Open Heart; 2021 Nov; 8(2):. PubMed ID: 34815301
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predicting Determinants of Atrial Fibrillation or Flutter for Therapy Elucidation in Patients at Risk for Thromboembolic Events (PREDATE AF) Study.
    Nasir JM; Pomeroy W; Marler A; Hann M; Baykaner T; Jones R; Stoll R; Hursey K; Meadows A; Walker J; Kindsvater S
    Heart Rhythm; 2017 Jul; 14(7):955-961. PubMed ID: 28506913
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anticoagulation in "real world" patients with atrial fibrillation in Italy: results from the ISPAF (Indagine Sicoa Paziente Con Fibrillazione Atriale) survey study.
    Volterrani M; Iellamo F; Rosano G; Guarini P; Pusineri E; Bonassi S; Chimini C; Zaccà F; Proto C;
    Int J Cardiol; 2013 Oct; 168(5):4729-33. PubMed ID: 23948115
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimising stroke prevention in patients with atrial fibrillation: application of the GRASP-AF audit tool in a UK general practice cohort.
    Shantsila E; Wolff A; Lip GY; Lane DA
    Br J Gen Pract; 2015 Jan; 65(630):e16-23. PubMed ID: 25548312
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of oral anticoagulation therapy in the first 3 months after the diagnosis of atrial fibrillation in Israel: A population-based study.
    Kezerle L; Tsadok MA; Berliner Senderey A; Hoshen M; Leventer-Roberts M; Reges O; Leibowitz M; Haim M
    J Cardiovasc Electrophysiol; 2020 Jun; 31(6):1356-1363. PubMed ID: 32212197
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quality of care in patients with atrial fibrillation in primary care: a cross-sectional study comparing clinical and claims data.
    Preuss R; Chenot JF; Angelow A
    Ger Med Sci; 2016; 14():Doc13. PubMed ID: 27980520
    [No Abstract]   [Full Text] [Related]  

  • 19. Underprescribing vs underfilling to oral anticoagulation: An analysis of linked medical record and claims data for a nationwide sample of patients with atrial fibrillation.
    Guo JS; He M; Gabriel N; Magnani JW; Kimmel SE; Gellad WF; Hernandez I
    J Manag Care Spec Pharm; 2022 Dec; 28(12):1400-1409. PubMed ID: 36427343
    [No Abstract]   [Full Text] [Related]  

  • 20. Impact of oral anticoagulation in patients with atrial fibrillation at very low thromboembolic risk.
    Verbrugge FH; Martin AC; Siegal D; Pieper K; Illingworth L; Camm AJ; Fox KAA
    Heart; 2020 Jun; 106(11):845-851. PubMed ID: 31806700
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.